Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication overuse headache.

Volker Limmroth1, Zaza Katsarava

  • 1Department of Neurology, University Hospital Essen, Essen, Germany. volker.limmroth@uni-essen.de

Current Opinion in Neurology
|May 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Cephalalgia : an international journal of headache·2026
Same author

Over 600 million people aged 18-65 will have headache tomorrow: global 1-day prevalence and recall bias from a meta-analysis of individual participant data (N = 38,512) from the general populations of 15 countries.

The journal of headache and pain·2026
Same author

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study.

Annals of clinical and translational neurology·2026
Same author

MIDAS and HIT-6 Questionnaires Versus Headache Diaries for Monitoring Treatment Response to Erenumab in Migraine: A REFORM Study.

European journal of neurology·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

The prevalence of headache disorders among children and adolescents in Georgia: a cross-sectional schools-based study.

The journal of headache and pain·2025
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Medication overuse headache is a common but unrecognized condition. New data on critical dosages and relapse predictors may inform future treatment guidelines.

Area of Science:

  • Neurology
  • Headache Medicine

Background:

  • Medication overuse headache (MOH) is a prevalent, yet often unrecognized, cause of chronic headaches.
  • It is now considered the third most common headache disorder globally, following tension-type headache and migraine.
  • Previous classifications were based on 1980s drug availability, necessitating an update.

Purpose of the Study:

  • To review current literature on medication overuse headache (MOH).
  • To analyze clinical presentation, pathophysiology, therapy, and prognosis in light of new headache classifications.
  • To incorporate recent epidemiological and clinical findings.

Main Methods:

  • Literature review of current scientific publications.
  • Analysis of epidemiological data on headache prevalence.

Related Experiment Videos

  • Examination of clinical features and treatment outcomes for MOH.

    • Main Results:

    • MOH is a significant public health issue, affecting a large patient population.
    • Updated data on critical monthly dosages and intake frequencies for key anti-headache medications (e.g., triptans) are now available.
    • Prospective studies have identified relapse rates and predictors following successful withdrawal treatments.

    Conclusions:

    • Recent findings provide a foundation for developing future consensus guidelines for MOH management.
    • Updated understanding of MOH is crucial for effective clinical practice and patient outcomes.
    • Further research may refine diagnostic criteria and therapeutic strategies for MOH.